Highbridge Capital Management LLC Abbott Laboratories Call Options Transaction History

Highbridge Capital Management LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $407,427 - $491,512	-6,700 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $184,224 - $203,328	3,200 Added 91.43%	6,700 $408,000
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $759,645 - $858,870	-13,500 Reduced 79.41%	3,500 $210,000
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $300,608 - $321,832	-5,600 Reduced 24.78%	17,000 $970,000
Q3 2017 Nov 14, 2017	SELL	$48.06 - $53.64 $326,808 - $364,752	-6,800 Reduced 23.13%	22,600 $1.21 Million
Q2 2017 Aug 14, 2017	BUY	N/A	29,400	29,400 $1.43 Million

3,208

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $224B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Highbridge Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Highbridge Capital Management LLC with notifications on news.